麒麟信安(688152.SH):麒麟信安操作系統作為聯營商品已上架華為云云商店
格隆匯4月18日丨麒麟信安(688152.SH)在投資者互動平台表示,公司是華為在歐拉生態和鯤鵬生態的重要合作伙伴,作為openEuler社區常務委員單位、首批openEuler商業發行版廠商,麒麟信安率先發布了基於openEuler的操作系統商業發行版本並持續迭代,與華為合作打造了基於鵬數字底座的全場景國產化解決方案,形成“麒麟信安操作系統+麒麟信安雲桌面+麒麟信安雲平台+鯤鵬服務器”的解決方案並在多個關鍵領域實現應用。同時,麒麟信安操作系統作為聯營商品已上架華為云云商店。未來,公司將繼續保持與華為的良好合作關係,積極探索更多有利於公司發展的合作機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.